logo
15:45 Dec 05

Brooks Laboratories Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals
Up
97.82
-0.68 (-0.69%)
Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

Brooks Laboratories Ltd. Financials

Brooks Laboratories Ltd.
Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Up
97.82
-0.68 (-0.69%)
15:45 Dec 05
Quality
image/svg+xml

41/100
Medium Financial Strength

Valuation
image/svg+xml

44/100
Mid Valuation

Technical

37/100
Technically Neutral

Strength

6

Weakness

7

Opportunity

1

Threats

0

-10.15 %

ROE %

-8.05 %

ROA %

3.91

EPS

33.30

BVPS

-12.07 %

Net Profit Margin

Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM 2025
Net Sales
91.08 63.2 79.49 82.56 110.73
Operating Expenses +
105.43 89.62 76.28 77.62 101.68
Raw Material
64.89 46.42 55.22 54.22 71.03
Increase Decrease in Cost
-2.1 4.18 1.4 -0.15 -0.55
Other Manufacturing Expense
9.51 7.13 4.44 0 0
Employee Cost
19.15 17.34 10.54 12.96 17.35
Miscellaneous Expenses
17.9 24.29 25.68 24.95 13.85
Operating Profit
-14.35 -26.42 3.21 4.94 9.05
Other Income
0.91 0.2 0.96 0.88 1.33
Depreciation
7.35 7.03 1.77 1.6 1.95
Interest
3.1 2.18 0.84 1.03 1.29
Profit before tax and exceptio..
-23.9 -35.42 1.55 3.19 7.14
Exceptional Items
0 0.36 0 0 0
PBT
-23.9 -35.07 1.55 3.19 7.14
Provision for Taxation
-4.59 -7.32 0.03 0.18 0.21
Net Profit
-19.31 -27.74 1.53 3.02 6.93
NET Profit after MI
-16.19 -20.9 -19.59 -9.97 11.53
EPS
-7.82 -12.57 -7.65 -3.72 3.67
Operating Profit Margin (%)
-15.76 -41.8 4.04 5.98 8.17
Net Profit Margin (%)
-17.78 -33.07 -24.64 -12.08 10.41

Brooks Laboratories Ltd. Shareholding

Promoter

FII

Public

All Data in Percentage (%)

Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025
Promoter 52.60 52.60 52.60 59.10 63.60 63.60
FII 0.00 0.00 0.00 0.00 0.00 0.00
Public 10.40 10.40 10.40 3.90 3.90 3.90
Others 37.00 37.00 37.00 37.00 32.50 32.50
Shareholder Shares Holding %
Research 360 logo
Download Our App On: